Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2015

Open Access 01-12-2015 | Case report

Male breast carcinoma: radiotherapy contributed to favorable local control in two cases and related literature review

Authors: Min Liu, Qiang Wang, Bin Liu, Ling Gao, Di Wu, Shuo Yang, Bailong Liu, Lihua Dong

Published in: European Journal of Medical Research | Issue 1/2015

Login to get access

Abstract

Male breast carcinoma (MBC) is rarely encountered in clinical practice. Due to its paucity, our knowledge of MBC only rely on small or single-institutional studies and sporadic cases. The current guidelines for MBC are extrapolated from its female counterparts Rudlowski (Breast Care (Basel) 3(3):183–189, 2008). Nowadays, MBC is actively studied and viewed as a potentially different entity on the aspects of etiology, biological behavior and prognosis. Thus, special treatment strategy guidelines should be established for MBC. Additionally, advance in the systemic chemotherapy and hormonal therapy also contribute to the local control. The indication of radiotherapy need to be clarified and over-treatment should be avoided. Here we present two cases of MBC in which radiotherapy help to sustain a satisfactory disease free survival. Our cases will provide valuable experience for identifying the role of radiotherapy in MBC.
Literature
1.
2.
Nahleh ZA. Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat Rev. 2006;32(2):101–5.CrossRefPubMed
3.
Hultborn R, Friberg S, Hultborn KA, Peterson LE, Ragnhult I. Male breast carcinoma. II. A study of the total material reported to the Swedish cancer Registry 1958 ± 1967 with respect to treatment, prognostic factors and survival. Acta Oncol. 1987;26(5):327–41.CrossRefPubMed
4.
5.
Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28(2):232–9.PubMedCentralCrossRefPubMed
6.
7.
Borgen PI, Wong GY, Vlamis V, Potter C, Hoffmann B, Kinne DW, Osborne MP, McKinnon WM. Current management of male breast cancer. A review of 104 cases. Ann Surg. 1992;215(5):451–7.PubMedCentralCrossRefPubMed
8.
Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, Bartlett JM, Gelmon K, Nahleh Z, Bergh J, Cutuli B, Pruneri G, McCaskill-Stevens W, Gralow J, Hortobagyi G, Cardoso F. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010;28(12):2114–22.PubMedCentralCrossRefPubMed
9.
Yoney A, Kucuk A, Unsal M. Male breast cancer: a retrospective analysis. Cancer Radiother. 2009;13(2):103–7.CrossRefPubMed
10.
Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A. MicroRNA expression profiling of male breast cancer. Breast Cancer Res. 2009;11(4):R58.PubMedCentralCrossRefPubMed
11.
Ferreira M, Mesquita M, Quaresma M, André S. Prolactin receptor expression in gynaecomastia and male breast carcinoma. Histopathology. 2008;53(1):56–61.CrossRefPubMed
12.
Younis T, Haché KD, Rayson D, Dewar R, Gray S, Barnes PJ. Survivin and COX-2 expression in male breast carcinoma. Breast. 2009;18(4):228–32.CrossRefPubMed
13.
Stranzl H, Mayer R, Quehenberger F, Prettenhofer U, Willfurth P, Stöger H, Hackl A. Adjuvant radiotherapy in male breast cancer. Radiother Oncol. 1999;53(1):29–35.CrossRefPubMed
14.
Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast. 2007;16(6):653–6.CrossRefPubMed
15.
16.
Yu E, Suzuki H, Younus J, Elfiki T, Stitt L, Yau G, Vujovic O, Perera F, Lock M, Tai P. The impact of post-mastectomy radiation therapy on male breast cancer patients: a case series. Int J Radiat Oncol Biol Phys. 2012;82(2):696–700.CrossRefPubMed
17.
Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother. 2007;8(2):193–202.CrossRefPubMed
18.
Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126(4):775–80 (discussion 780–771).CrossRefPubMed
19.
Atahan L, Yildiz F, Selek U, Sari S, Gurkaynak M. Postoperative radiotherapy in the treatment of male breast carcinoma: a single institute experience. J Natl Med Assoc. 2006;98(4):559–63.PubMedCentralPubMed
20.
Eggemann H, Ignatov A, Stabenow R, von Minckwitz G, Röhl FW, Hass P, Costa SD. Male breast cancer: 20-year survival data for post-mastectomy radiotherapy. Breast Care (Basel). 2013;8(4):270–5.CrossRef
21.
22.
Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996. Cancer. 1999;85(3):629–39.CrossRefPubMed
23.
Handesman D. Androgen actions and pharmacologic uses. In: Detroit IJ, editor. Endocrinology. Philadelphia: WB Saunders; 2001. p. 2232–42.
24.
25.
Pemmaraju N, Munsell MF, Hortobagyi GN, Giordano SH. Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects. Ann Oncol. 2012;23(6):1471–4.PubMedCentralCrossRefPubMed
26.
Sedighi A, Hamed EA, Mohammadian K, Behnood S, Kalaghchi B. Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of Hamedan, Iran. Asian Pac J Cancer Prev. 2013;14(12):7381–3.CrossRefPubMed
27.
Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol. 2010;73(3):246–54.CrossRefPubMed
Metadata
Title
Male breast carcinoma: radiotherapy contributed to favorable local control in two cases and related literature review
Authors
Min Liu
Qiang Wang
Bin Liu
Ling Gao
Di Wu
Shuo Yang
Bailong Liu
Lihua Dong
Publication date
01-12-2015
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2015
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-015-0173-x

Other articles of this Issue 1/2015

European Journal of Medical Research 1/2015 Go to the issue

Research

Proteomic analysis of exosomes derived from human lymphoma cells

Research

Is rs759853 polymorphism in promoter of aldose reductase gene a risk factor for diabetic nephropathy? A meta-analysis

Case report

Primary epididymis malignant triton tumor: case report and review of the literature

Research

An immunohistochemical study of CD83- and CD1a-positive dendritic cells in the decidua of women with recurrent spontaneous abortion

Case report

Acute quadriplegia caused by necrotizing myopathy in a renal transplant recipient with severe pneumonia: acute onset and complete recovery

Research

The effects of smoking and drinking on all-cause mortality in patients with dilated cardiomyopathy: a single-center cohort study